What is the most current recommendation for the treatment of latent tuberculosis?
Year: 2026
Type: article
Abstract: Multiple regimens are recommended for LTBI treatment, including 3-month regimens of isoniazid and rifapentine or rifampicin, and 6 to 9 months of isoniazid, depending on patient risk and adherence considerations.
Author: Tripdatabase
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7141664072
